Hypercholesterinämie - Triglyzeride
Figure 1: Triglyceride (TG) levels in patients with homozygous and heterozygous familial hypercholesterolaemia on long-term LDL-apheresis and concomitant (A) simvastatin (40 mg) or (B) atorvastatin (10 to 80 mg) therapy


Keywords: Apherese,  Apheresis,  Atorvastatin,  Atorvastatin,  Diagramm,  Heterozygotie,  Heterozygousity,  Homozygotie,  Homozygousity,  Hypercholesterinämie,  hypercholesterolaemia,  LDL,  LDL,  Simvastatin,  Simvastatin,  triglyceride,  Triglyzeride

Hypercholesterinämie - LDL
Figure 2: LDL-cholesterol in patients with homozygous and heterozygous familial hypercholesterolaemia on long-term LDL-apheresis and concomitant (A) simvastatin (40 mg) or (B) atorvastatin (10 to 80 mg) therapy


Keywords: Apherese,  Apheresis,  Atorvastatin,  Diagramm,  Heterozygotie,  Heterozygousity,  Homozygotie,  Homozygousity,  Hypercholesterinämie,  hypercholesterolaemia,  LDL,  LDL-cholesterol,  Simvastatin

Hypercholesterinämie - LDL
Figure 3: Time course of serum LDL-cholesterol levels in homozygous (n = 4) and heterozygous (n = 10) patients with familial hypercholesterolaemia undergoing LDL-apheresis treatment at weekly intervals. The recovery of LDL-cholesterol is given both the total value (mg/dl) and the percent decrease for the last 24 hours. These values were determined either without additional statin therapy for four weeks (wash-out period) or when patients were on 80 mg of atorvastatin for a four weeks.


Keywords: Apherese,  Apheresis,  Atorvastatin,  Atorvastatin,  Diagramm,  Heterozygotie,  Heterozygousity,  Homozygotie,  Homozygousity,  Hypercholesterinämie,  hypercholesterolaemia,  LDL,  LDL

LDL-Apherese - Fibrinogen
Figure 4: Fibrinogen concentrations obtained in patients treated long-term with LDL-apheresis and addition of different statin therapy. A: simvastatin (40 mg), B: atorvastatin 10 to 80 mg


Keywords: Apherese,  Apheresis,  Atorvastatin,  Atorvastatin,  Diagramm,  fibrinogen,  fibrinogen,  LDL,  LDL,  Simvastatin,  Simvastatin